XM does not provide services to residents of the United States of America.

Warby Parker fends off 1-800 Contacts' keyword ad case at US appeals court



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Warby Parker fends off 1-800 Contacts' keyword ad case at US appeals court</title></head><body>

By Blake Brittain

Oct 8 (Reuters) -Warby Parker WRBY.N convinced a federal appeals court on Tuesday to uphold a decision that its use of a competitor's name to redirect search-engine users to its online contact lens store did not violate U.S. trademark law.

The New York-based 2nd U.S. Circuit Court of Appeals said that 1-800 Contacts [RIC:RIC:FENWYO.UL] failed to prove Warby Parker's keyword advertising would deceive potential customers.

Warby Parker attorney Roxanne Elings of Davis Wright Tremaine said the company was "delighted" with the decision. An attorney and spokespeople for 1-800 Contacts did not immediately respond to a request for comment.

Warby Parker, best known for its eyeglasses, began selling contacts in 2019. 1-800 Contacts sued Warby Parker in 2021, accusing it of unlawfully buying keyword advertising on Google and other search engines to show Warby Parker ads when users search for "1-800 Contacts."

A federal judge in New York dismissed the case in 2022, finding that the marketing was not likely to confuse potential customers. The 2nd Circuit upheld the decision on Tuesday, adopting the "consensus view" of other circuits that have considered the same issue.

"Despite 1-800’s emphasis on the allegedly nefarious nature of Warby Parker’s keyword bidding activities, this well-known internet marketing strategy — by itself — does not support a claim of trademark infringement absent additional use of 1-800’s Marks," U.S. Circuit Judge Eunice Lee wrote for a three-judge panel.

The case is 1-800 Contacts Inc v. JAND Inc d/b/a Warby Parker, 2nd U.S. Circuit Court of Appeals, No. 22-1634.

For 1-800 Contacts: Stephen Fishbein of A&O Shearman

For Warby Parker: Roxanne Elings of Davis Wright Tremaine

Read more:

1-800 Contacts sues Warby Parker for trademark infringement over keyword ads

Warby Parker defeats 1-800 Contacts lawsuit over keyword ads



Reporting by Blake Brittain in Washington

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.